Racial and Ethnic Disparities in the Imaging Workup and Treatment of Knee and Hip Osteoarthritis

Wu, Mark; Case, Andrew D.; Kim, Billy; Cochrane, Niall H.; Nagy, Gabriela A.; Bolognesi, Michael P.; Seyler, Thorsten M.

doi:10.1016/j.arth.2022.02.019

Cited by 7 publications

(11 citation statements)

References 40 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“… 41 In addition, a study of knee or hip OA patients in a tertiary center in North Carolina found that AAs were likely than WHs to receive an intra-articular knee, but not hip, joint injection. 33 Race differences persisted after adjustment for patient sociodemographic characteristics in both studies. 33 , 41 …”

Section: Resultsmentioning

confidence: 86%

“… 33 Race differences persisted after adjustment for patient sociodemographic characteristics in both studies. 33 , 41 …”

Section: Resultsmentioning

confidence: 86%

“…In Katz and Lee’s 45 investigation, 83% of Asian Americans compared to 89% of WHs reported use of any CAM therapy for OA. In Wu et al ’.s 33 investigation, Asians may be less likely than WHs (28.7% vs 34.0%) to receive a knee injection for OA. The dearth of studies on use of OA treatments by Asians is likely due to the small number of Asian Americans represented and recruited.…”

Section: Discussionmentioning

confidence: 93%

“…Many (7 studies) used International Classification of Disease–9 diagnosis codes. 27 – 33 Others (8 studies) used self-report questionnaires such as The National Health and Nutrition Examination Survey criteria. 34 – 41 Table 1 summarizes the clinical setting, the characteristics of the sample population, and the pharmacologic treatment utilization measure of all studies included ( n = 21).…”

Section: Resultsmentioning

confidence: 99%

“…A few studies have investigated potential race differences in the use of intra-articular therapies among those with OA ( Table 4 ). 33 , 39 , 41 , 43 AA OAI study participants were as likely as WH OAI study participants to report receiving intra-articular glucocorticoid and hyaluronic acid knee injections for joint pain or arthritis in the past 30 days. 39 Similarly, Abbate et al ’.s 43 study of OA clinical trial participants living in North Carolina found that intra-articular knee injection use did not differ between AAs and WHs.…”

Section: Resultsmentioning

confidence: 99%

See 4 more Smart Citations

Racial and ethnic differences in the pharmacologic management of osteoarthritis: rapid systematic review

Vina

Tsoukas

Abdollahi

et al. 2022

Therapeutic Advances in Musculoskeletal

View full text Add to dashboard Cite

Background: Racial and ethnic disparities in osteoarthritis (OA) patients’ disease experience may be related to marked differences in the utilization and prescription of pharmacologic treatments. Objectives: The main objective of this rapid systematic review was to evaluate studies that examined race/ethnic differences in the use of pharmacologic treatments for OA. Data sources and methods: A literature search (PubMed and Embase) was ran on 25 February 2022. Studies that evaluated race/ethnic differences in the use of OA pharmacologic treatments were included. Two reviewers independently screened titles and abstracts and abstracted data from full-text articles. Preferred Reporting Items of Systematic Reviews and Meta-Analyses (PRISMA) guidelines were followed. Results: The search yielded 3880 titles, and 17 studies were included in this review. African Americans and Hispanics were more likely than non-Hispanic Whites to use prescription non-selective non-steroidal anti-inflammatory drugs (NSAIDs) for OA. However, compared to non-Hispanic Whites with OA, African Americans and Hispanics with OA were less likely to receive a prescription for cyclooxygenase-2-selective NSAIDs and less likely to report the use of joint health supplements (i.e. glucosamine and chondroitin sulfate). There were minimal/no significant race/ethnic differences in the patient-reported use of the following OA therapies: acetaminophen, opioids, and other complementary/alternative medicines (vitamins, minerals, and herbs). There were also no significant race differences in the receipt of intra-articular therapies (i.e. glucocorticoid or hyaluronic acid). However, there is limited evidence to suggest that African Americans may be less likely than Whites to receive opioids and intra-articular therapies in some OA patient populations. Conclusion: This systematic review provides an overview of the current pharmacologic options for OA, with a focus on race and ethnic differences in the use of such medical therapies.

show abstract

Section: Resultsmentioning

confidence: 86%

“… 33 Race differences persisted after adjustment for patient sociodemographic characteristics in both studies. 33 , 41 …”

Section: Resultsmentioning

confidence: 86%

Section: Discussionmentioning

confidence: 93%

Section: Resultsmentioning

confidence: 99%

Section: Resultsmentioning

confidence: 99%

See 3 more Smart Citations

Racial and ethnic differences in the pharmacologic management of osteoarthritis: rapid systematic review

Vina

Tsoukas

Abdollahi

et al. 2022

Therapeutic Advances in Musculoskeletal

View full text Add to dashboard Cite

show abstract

Racialized Inequities in Knee Arthroplasty Receipt After Osteoarthritis Diagnosis in the US Military Health System

Sowa,

Patzkowski,

Ismawan

et al. 2024

Arthritis Care & Research

View full text Add to dashboard Cite

ObjectiveTo evaluate institutional inequities in the US Military Health System in knee arthroplasty receipt within three years of knee osteoarthritis diagnosis when accounting for other treatments received (e.g., physical therapy, medications).MethodsIn this retrospective observational cohort study, medical record data of patients (N =29,734) who received a primary osteoarthritis diagnosis in the US Military Health System between January 2016 to January 2020 were analyzed. Data included receipt of physical therapy 1‐year pre‐diagnosis and up to 3‐years post‐diagnosis, pre‐diagnosis opioid and non‐opioid prescription receipt, health‐related factors associated with levels of racism, and the primary outcome, knee arthroplasty receipt within 3‐years post‐diagnosis.ResultsIn a generalized additive model with time‐varying covariates, Asian and Pacific Islander (Incidence Rate Ratio (IRR) 0.58; 95% CI 0.45, 0.74), Black (IRR 0.52; 95%CI 0.46, 0.59), and Latinx (IRR 0.66; 95%CI 0.52, 0.85) patients experienced racialized inequities in knee arthroplasty receipt, relative to white patients (all p < 0.001).ConclusionsIn the present sample, Asian and Pacific Islander, Black, and Latinx patients were significantly less likely to receive a knee arthroplasty, relative to white patients. Taken together, system‐level resources are needed to identify and address mechanisms underlying institutional inequities in knee arthroplasty receipt, such as factors related to systemic and structural, institutional, and personally‐mediated racism.

show abstract

Health Disparities and Diversity Research Presented at the American Association of Hip and Knee Surgeons 2021 Annual Meeting

2022

View full text Add to dashboard Cite

Racial and Ethnic Disparities in the Imaging Workup and Treatment of Knee and Hip Osteoarthritis

Cited by 7 publications

References 40 publications

Racial and ethnic differences in the pharmacologic management of osteoarthritis: rapid systematic review

Racial and ethnic differences in the pharmacologic management of osteoarthritis: rapid systematic review

Racialized Inequities in Knee Arthroplasty Receipt After Osteoarthritis Diagnosis in the US Military Health System

Health Disparities and Diversity Research Presented at the American Association of Hip and Knee Surgeons 2021 Annual Meeting

Contact Info

Product

Resources

About